Rapid Conversion of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia in a Patient on Imatinib Therapy

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2016 Aug 3

PMID 27480386

Citations 3

Authors

J S Khorashad

S K Tantravahi

D Yan

C C Mason

Y Qiao

A M Eiring

K Gligorich

T Hein

A D Pomicter

A G Reid

T W Kelley

G T Marth

T OHare

M W Deininger

Affiliations

Soon will be listed here.

Citing Articles

Case report: Co-existing chronic myeloid leukemia and chronic myelomonocytic leukemia-A clinically important but challenging scenario.

Song J, Moscinski L, Zhang L, Zhang H Leuk Res Rep. 2023; 20:100378.

PMID: 37415731 PMC: 10319893. DOI: 10.1016/j.lrr.2023.100378.

Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.

Zhao H, Deininger M Blood. 2023; 141(23):2797-2812.

PMID: 36947811 PMC: 10315634. DOI: 10.1182/blood.2022017152.

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Valent P, Orazi A, Savona M, Patnaik M, Onida F, van de Loosdrecht A Haematologica. 2019; 104(10):1935-1949.

PMID: 31048353 PMC: 6886439. DOI: 10.3324/haematol.2019.222059.

References

Diamond J, Goldman J, Melo J . BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood. 1995; 85(8):2171-5. View

Padron E, Abdel-Wahab O . Importance of genetics in the clinical management of chronic myelomonocytic leukemia. J Clin Oncol. 2013; 31(19):2374-6. DOI: 10.1200/JCO.2013.48.9120. View

Chang K, Pastan I . Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A. 1996; 93(1):136-40. PMC: 40193. DOI: 10.1073/pnas.93.1.136. View

Bumm T, Muller C, Al-Ali H, Krohn K, Shepherd P, Schmidt E . Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood. 2002; 101(5):1941-9. DOI: 10.1182/blood-2002-07-2053. View

Deininger M, Goldman J, Melo J . The molecular biology of chronic myeloid leukemia. Blood. 2000; 96(10):3343-56. View

Grossmann V, Kohlmann A, Eder C, Haferlach C, Kern W, Cross N . Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia. 2011; 25(5):877-9. DOI: 10.1038/leu.2011.10. View

Schmidt M, Rinke J, Schafer V, Schnittger S, Kohlmann A, Obstfelder E . Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia. 2014; 28(12):2292-9. DOI: 10.1038/leu.2014.272. View

Kim M, Kim G, Choi Y, Kim H, Kim Y, Jin W . TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1. Mol Cells. 2013; 36(2):177-84. PMC: 3887946. DOI: 10.1007/s10059-013-0061-6. View

Lannon C, Sorensen P . ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol. 2005; 15(3):215-23. DOI: 10.1016/j.semcancer.2005.01.003. View

10.

Mason C, Khorashad J, Tantravahi S, Kelley T, Zabriskie M, Yan D . Age-related mutations and chronic myelomonocytic leukemia. Leukemia. 2015; 30(4):906-13. PMC: 5096889. DOI: 10.1038/leu.2015.337. View

11.

Dulak A, Stojanov P, Peng S, Lawrence M, Fox C, Stewart C . Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013; 45(5):478-86. PMC: 3678719. DOI: 10.1038/ng.2591. View

12.

Onda M, Nagata S, Ho M, Bera T, Hassan R, Alexander R . Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res. 2006; 12(14 Pt 1):4225-31. DOI: 10.1158/1078-0432.CCR-06-0472. View

13.

Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C . Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013; 121(12):2186-98. DOI: 10.1182/blood-2012-06-440347. View

14.

Loriaux M, Deininger M . Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib. Leuk Lymphoma. 2004; 45(11):2197-203. DOI: 10.1080/10428190410001723278. View

15.

Klco J, Spencer D, Miller C, Griffith M, Lamprecht T, OLaughlin M . Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell. 2014; 25(3):379-92. PMC: 3983786. DOI: 10.1016/j.ccr.2014.01.031. View